Literature DB >> 31084233

pH-responsive hyaluronic acid nanoparticles coloaded with sorafenib and cisplatin for treatment of hepatocellular carcinoma.

Wei Zhang1, Jinzhen Cai1, Bin Wu1, Zhongyang Shen1.   

Abstract

Entities:  

Keywords:  Hepatocellular carcinoma; cisplatin; hyaluronic acid; pH-responsive release; sorafenib

Mesh：

Substances：

Year:  2019        PMID： 31084233     DOI： 10.1177/0885328219849711

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN： 0885-3282            Impact factor:   2.646


× No keyword cloud information.
  4 in total

Review 1.  Synthesis of self-assembled hyaluronan based nanoparticles and their applications in targeted imaging and therapy.

Authors:  Kunli Liu; Xuefei Huang
Journal:  Carbohydr Res       Date:  2022-01-05       Impact factor: 2.104

Review 2.  Hyaluronic Acid within Self-Assembling Nanoparticles: Endless Possibilities for Targeted Cancer Therapy.

Authors:  Manuela Curcio; Orazio Vittorio; Jessica Lilian Bell; Francesca Iemma; Fiore Pasquale Nicoletta; Giuseppe Cirillo
Journal:  Nanomaterials (Basel)       Date:  2022-08-18       Impact factor: 5.719

Review 3.  Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy.

Authors:  Fangmin Chen; Yifan Fang; Xiang Chen; Rui Deng; Yongjie Zhang; Jingwei Shao
Journal:  Asian J Pharm Sci       Date:  2020-08-21       Impact factor: 6.598

4.  Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid.

Authors:  Zhuo-Yue Li; Yi-Fan Yin; Yang Guo; Hui Li; Mei-Qi Xu; Man Liu; Jing-Ru Wang; Zhen-Han Feng; Xiao-Chuan Duan; Shuang Zhang; Shuai-Qiang Zhang; Guang-Xue Wang; Ai Liao; Shu-Min Wang; Xuan Zhang
Journal:  Int J Nanomedicine       Date:  2020-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.